Glass House Brands Subordinate Voting Shares (GLAS) vs Regencell Bioscience (RGC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Glass House Brands Subordinate Voting Shares (GLAS) has outperformed Regencell Bioscience (RGC) over the past year, losing 44.9% versus a loss of 64.5%. Over five years, RGC leads with a +1349.5% price change compared with -11.7% for GLAS.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GLAS | RGC |
|---|---|---|
| Share price | $4.41 | $7.63 |
| Market cap | $415.61M | — |
| 1-day change | -14.04% | +7.31% |
| YTD return | -50.17% | -66.14% |
| 1-year return | -44.88% | -64.54% |
| 5-year return | -11.71% | +1349.54% |
| Forward P/E | 19.60 | — |
| EPS (TTM) | $-0.74 | $-0.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-11.70M |
| 52-week high | $13.93 | $69.00 |
| 52-week low | $4.20 | $4.51 |
| Distance from 52-week high | -68.34% | -88.94% |
| Analyst consensus | none | — |
| Avg. price target upside | +262.81% | — |
| Average volume | 736.52K | 205.08K |
| Shares outstanding | 88.00M | — |
| Employees | 357 | 10 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GLAS has outperformed RGC by 19.7 percentage points over the past year.
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
GLAS vs RGC FAQ
Which stock has performed better over the past year, GLAS or RGC?
GLAS returned -44.88% over the past 12 months, compared with -64.54% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Glass House Brands Subordinate Voting Shares and Regencell Bioscience in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.